BIO-RAD LABORATORIES, INC. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 12.31.20 - February 12, 2021

Attached files

file filename
EX-31.1 - EX-31.1 CEO SECTION 302 CERTIFICATION 12.31.20 - BIO-RAD LABORATORIES, INC.ex311123120.htm
10-K - 10-K 12.31.20 - BIO-RAD LABORATORIES, INC.bio-20201231.htm
EX-32.2 - EX-32.2 CFO SECTION 906 CERTIFICATION 12.31.20 - BIO-RAD LABORATORIES, INC.ex322123120.htm
EX-32.1 - EX-32.1 CEO SECTION 906 CERTIFICATION 12.31.20 - BIO-RAD LABORATORIES, INC.ex321123120.htm
EX-31.2 - EX-31.2 CFO SECTION 302 CERTIFICATION 12.31.20 - BIO-RAD LABORATORIES, INC.ex312123120.htm
EX-21.1 - EXHIBIT 21.1 12.31.20 - BIO-RAD LABORATORIES, INC.ex211123120.htm

Exhibit 23.1



Consent of Independent Registered Public Accounting Firm




The Board of Directors
Bio-Rad Laboratories, Inc.:

We consent to the incorporation by reference in the registration statement on Forms S-8 (Nos. 333-220219, 333-144962, 333-133507, 333-124187, 333-53335, 333-53337, 333-179876, 333-197979, and 333-206885) of Bio-Rad Laboratories, Inc. of our reports dated February 12, 2021, with respect to the consolidated balance sheets of Bio-Rad Laboratories, Inc. as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, changes in stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2020 and the effectiveness of internal control over financial reporting as of December 31, 2020, which reports appear in the December 31, 2020 annual report on Form 10-K of Bio-Rad Laboratories, Inc.

Our report refers to a change in the accounting method for lease recognition in 2019.


/s/ KPMG LLP

Santa Clara, California
February 12, 2021


BIO-RAD LABORATORIES, INC. Reports